PrescriptionDrugs.org

What to Expect When Starting Spironolactone

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.

Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.

Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.

See our Terms of Use and Editorial Policy.

Introduction

Spironolactone is a potassium-sparing diuretic and aldosterone receptor antagonist with a remarkably versatile range of clinical applications [1]. Originally developed for heart failure and hypertension, it is now widely prescribed for conditions including resistant hypertension, heart failure with reduced ejection fraction, liver cirrhosis with ascites, primary hyperaldosteronism, hormonal acne, hirsutism, and as part of feminizing hormone therapy [2]. Its anti-androgenic properties make it uniquely useful among diuretics.

Spironolactone works by competitively blocking aldosterone receptors in the distal nephron, which reduces sodium and water reabsorption while preserving potassium [1]. It also blocks androgen receptors and inhibits testosterone synthesis, which accounts for its effectiveness in androgen-mediated conditions like acne and hirsutism, as well as its hormonal side effects [2]. The landmark RALES trial demonstrated a 30% reduction in mortality when spironolactone was added to standard heart failure therapy [3].

This guide covers what to expect when starting spironolactone, including the gradual onset of effects, the importance of potassium monitoring, common side effects, and when to contact your healthcare provider. Because spironolactone affects potassium levels, regular blood work is essential, especially when starting the medication or changing doses.

Week-by-week timeline

Days 1-3Take spironolactone with food to improve absorption and reduce GI side effects. Morning dosing is preferred to avoid nighttime urination [1].

Starting treatment

Spironolactone is absorbed from the GI tract and extensively metabolized to active metabolites, primarily canrenone, which has a half-life of approximately 16-20 hours [1]. Diuretic effects begin within 2-3 days, but the full antihypertensive and anti-androgenic effects take considerably longer to develop. In the first few days, you may notice a mild increase in urination as the diuretic effect begins [2].

  • Mild increase in urination frequency
  • No immediate blood pressure or skin changes — these take weeks
  • Possible mild GI discomfort (nausea, diarrhea)
  • Taking the medication with food improves absorption
Week 1-2Attend all scheduled lab appointments. Hyperkalemia can be dangerous and is often asymptomatic until severe — monitoring is the only way to detect it [1][2].

Diuretic effect established

The diuretic and potassium-sparing effects are established within 1-2 weeks [1]. Your provider will typically check potassium and kidney function (creatinine) within 1-2 weeks of starting, as hyperkalemia (elevated potassium) is the most clinically significant risk [2]. Blood pressure may begin to decrease. Patients taking spironolactone for heart failure may notice reduced fluid retention and improved breathing [3].

  • Measurable diuretic effect established
  • Blood work to check potassium and kidney function
  • Possible early blood pressure reduction
  • For heart failure: possible improvement in fluid retention
  • Mild dizziness if blood pressure drops, especially when standing
Weeks 3-8Breast tenderness and gynecomastia are dose-dependent and usually reversible if the dose is reduced [1]. Report these to your provider rather than stopping the medication.

Gradual therapeutic effects

Antihypertensive effects continue to build over 4-6 weeks [2]. For patients taking spironolactone for acne or hirsutism, anti-androgenic effects are not typically noticeable until 2-3 months of treatment, as the hormonal changes need time to affect hair growth cycles and sebaceous gland activity [4]. Hormonal side effects may emerge during this period — breast tenderness or gynecomastia in men occurs in approximately 10-15% of patients, and menstrual irregularities in women occur in about 10-20% [1][2].

  • Blood pressure progressively improving
  • For acne/hirsutism: minimal visible changes yet (patience required)
  • Possible breast tenderness (both sexes)
  • Possible menstrual irregularity in women
  • Ongoing potassium monitoring per provider schedule
Month 3+Continue taking spironolactone as prescribed even when feeling well. For heart failure, stopping can lead to disease progression. For acne, stopping typically results in gradual symptom return [2][4].

Full effects and maintenance

By 3 months, all therapeutic effects should be evident. For acne patients, studies show significant improvement in inflammatory lesions by months 3-6 [4]. For heart failure, the mortality benefit demonstrated in RALES was evident within months of starting therapy [3]. Long-term use requires ongoing potassium monitoring, though the frequency can decrease once levels are stable — typically every 3-6 months [2]. Kidney function should also be monitored periodically.

  • Full therapeutic effect achieved for all indications
  • For acne: visible improvement in skin
  • For heart failure: sustained improvement in symptoms and function
  • Stable potassium levels with periodic monitoring
  • Long-term medication routine well-established

When to call your doctor

Contact your healthcare provider if you experience:

  • Symptoms of hyperkalemia: muscle weakness, tingling or numbness, irregular or slow heartbeat, nausea — potassium above 5.5 mEq/L is dangerous [1][2]
  • Severe dizziness, fainting, or lightheadedness — may indicate blood pressure dropping too low [1]
  • Signs of dehydration: excessive thirst, very dark urine, confusion, rapid heartbeat [1]
  • Severe breast pain or significant breast enlargement in men [1]
  • Signs of allergic reaction: rash, hives, swelling, difficulty breathing [1]
  • Severe stomach pain, vomiting, or persistent diarrhea
  • Irregular menstrual bleeding that is heavy or prolonged in women [2]
  • Signs of kidney problems: significant decrease in urination, swelling in legs or feet [1]

Tips for getting started

Take spironolactone with food — this significantly improves absorption and reduces stomach upset [1]. Consistency in timing helps maintain steady blood levels. If prescribed once daily, morning dosing minimizes nighttime urination. If prescribed twice daily, take the second dose in the early afternoon.

Be cautious with potassium intake while on spironolactone. Avoid potassium supplements, salt substitutes (which contain potassium chloride), and excessive consumption of high-potassium foods like bananas, oranges, potatoes, and tomatoes unless directed by your provider [1][2]. Do not use NSAIDs (ibuprofen, naproxen) without medical guidance, as they can increase potassium levels and reduce spironolactone effectiveness.

Attend all lab appointments for potassium and kidney function monitoring — this is not optional. Hyperkalemia can cause life-threatening cardiac arrhythmias and is often asymptomatic until dangerous levels are reached [2]. If you are taking spironolactone for acne, be patient — improvement typically takes 2-3 months and may continue to improve for up to 6 months. Use appropriate contraception if sexually active, as spironolactone can cause birth defects (FDA pregnancy category X for certain uses) [1].

Frequently asked questions

More about Spironolactone

References

  1. [Regulatory] Spironolactone FDA Prescribing Information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/012151s079lbl.pdf Accessed 2026-03-01.
  2. [Regulatory] Spironolactone. StatPearls [Internet]. National Library of Medicine. https://www.ncbi.nlm.nih.gov/books/NBK554421/ Accessed 2026-03-01.
  3. [Clinical] Pitt B, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure (RALES). N Engl J Med. 1999;341(10):709-717. https://pubmed.ncbi.nlm.nih.gov/10471456/ Accessed 2026-03-01.
  4. [Clinical] Kim GK, Del Rosso JQ. Oral spironolactone in post-teenage female patients with acne vulgaris. J Clin Aesthet Dermatol. 2012;5(3):37-50. https://pubmed.ncbi.nlm.nih.gov/22468178/ Accessed 2026-03-01.

Written and fact-checked by PrescriptionDrugs.org Editorial Team

Last updated: